A single tube 10-color flow cytometry assay optimizes detection of minimal residual disease in chronic lymphocytic leukemia
Author:
Publisher
Wiley
Subject
Cell Biology,Histology,Pathology and Forensic Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cyto.b.21067/fullpdf
Reference17 articles.
1. Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: A multivariate analysis from the randomized GCLLSG CLL8 trial;Bottcher;J Clin Oncol,2012
2. Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: The need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome;Montillo;Cancer Invest,2005
3. Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: Where do we stand?;Van Den Neste;Leuk Lymphoma,2012
4. Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry;Cabezudo;Leukemia,1997
5. A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells;Cragg;Blood,2004
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MRD-directed therapy in CLL: ready for prime time?;Hematology;2023-12-08
2. Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patients;Annales de Biologie Clinique;2023-08
3. The evolving use of measurable residual disease in chronic lymphocytic leukemia clinical trials;Frontiers in Oncology;2023-02-22
4. Flow cytometric evaluation of measurable residual disease in chronic lymphocytic leukemia: Where do we stand?;Hematological Oncology;2022-06-21
5. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations;Leukemia;2021-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3